Insider · CIK 0001181955
Robert J Eide
Files at MTNB (Matinas BioPharma Holdings, Inc.). First filing -, latest -.
Robert J Eide files SEC Form 4 as 10% owner at MTNB (Matinas BioPharma Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert J Eide has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 8, 2025 | MTNB Matinas BioPharma Holdings, Inc. | POpen-market purchase Series C Convertible Preferred Stockderivativeindirect: R. Eide as managing partner for Pembroke | +492 | $1,000.00 | $492k | 984 | Apr 10, 2025 |
| Apr 8, 2025 | MTNB Matinas BioPharma Holdings, Inc. | POpen-market purchase Warrantsderivativeindirect: R. Eide as managing partner for Pembroke | +1,679,182 | - | - | 3,358,364 | Apr 10, 2025 |
Questions about Robert J Eide
Answered from the filings on this page, as of the latest one.
Is Robert J Eide buying or selling?
Robert J Eide has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert J Eide's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert J Eide has 0.
Where does Robert J Eide file Form 4?
Robert J Eide has filed Form 4 at MTNB (Matinas BioPharma Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.